Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

PCOS has a strong genetic basis, but more research is needed to fully understand it.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Activating a protein called β-catenin in adult skin can make it behave like young skin, potentially helping with skin aging and hair loss.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Non-drug methods like diet, supplements, and aromatherapy can help manage hair loss and its emotional impact.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Male pattern baldness involves genetics, hormones, and needs better treatments.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Finasteride boosts stem cell signals for hair growth.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Minoxidil and finasteride effectively treat hair loss.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.